tiprankstipranks
Trending News
More News >
Poppins Corporation (JP:7358)
:7358
Japanese Market
Advertisement

Poppins Corporation (7358) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7358

Poppins Corporation

(7358)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
¥1,619.00
▲(12.51% Upside)
Poppins Corporation's strong financial performance is the most significant factor driving its overall score, supported by solid revenue growth, profitability, and cash flow management. The valuation is reasonable, with an attractive dividend yield. Technical analysis presents mixed signals, with short-term weakness but longer-term support. The absence of earnings call and corporate events data does not impact the score.

Poppins Corporation (7358) vs. iShares MSCI Japan ETF (EWJ)

Poppins Corporation Business Overview & Revenue Model

Company Description
How the Company Makes Money

Poppins Corporation Financial Statement Overview

Summary
Poppins Corporation exhibits strong financial performance with solid revenue and profit growth, financial stability with moderate leverage, and robust cash generation and management. The company is well-positioned for continued growth and stability in the personal products & services industry.
Income Statement
85
Very Positive
Poppins Corporation has shown strong revenue growth with a 9.68% increase from 2023 to 2024. The gross profit margin is healthy at 20.77%, and the net profit margin improved to 2.45%. EBIT and EBITDA margins are 4.97% and 4.78%, respectively, indicating efficient operations. Overall, the income statement reflects solid growth and profitability.
Balance Sheet
78
Positive
The company maintains a stable financial position with a debt-to-equity ratio of 0.47, indicating moderate leverage. The return on equity is 9.12%, showing effective use of equity to generate profits. The equity ratio stands at 50.89%, reflecting a balanced capital structure. The balance sheet suggests financial stability with manageable debt levels.
Cash Flow
82
Very Positive
Poppins Corporation has demonstrated significant improvement in cash flow, with a free cash flow growth rate of 242.91% from 2023 to 2024. The operating cash flow to net income ratio is 2.37, indicating strong cash generation relative to net income. The free cash flow to net income ratio is 1.52, showcasing efficient cash management. The cash flow statement highlights robust cash flow growth and effective capital allocation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue33.18B31.69B28.89B26.26B24.75B23.05B
Gross Profit7.08B6.58B5.94B5.60B5.34B5.05B
EBITDA1.67B1.51B1.37B1.47B1.75B1.87B
Net Income916.00M776.00M677.00M824.00M966.00M1.05B
Balance Sheet
Total Assets16.33B16.71B14.62B12.55B13.13B14.53B
Cash, Cash Equivalents and Short-Term Investments8.13B8.37B5.00B4.24B6.35B8.13B
Total Debt2.29B3.98B2.65B1.45B2.26B4.27B
Total Liabilities7.61B8.21B6.51B4.73B5.75B7.77B
Stockholders Equity8.72B8.51B8.12B7.82B7.38B6.76B
Cash Flow
Free Cash Flow0.001.18B-825.00M-1.46B453.00M151.00M
Operating Cash Flow0.001.84B771.00M304.00M1.28B1.08B
Investing Cash Flow0.00598.00M-827.00M-1.21B-690.00M-274.00M
Financing Cash Flow0.00933.00M815.00M-1.20B-2.36B3.26B

Poppins Corporation Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1439.00
Price Trends
50DMA
1472.62
Negative
100DMA
1402.63
Positive
200DMA
1281.91
Positive
Market Momentum
MACD
-5.29
Positive
RSI
44.25
Neutral
STOCH
22.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7358, the sentiment is Negative. The current price of 1439 is below the 20-day moving average (MA) of 1474.90, below the 50-day MA of 1472.62, and above the 200-day MA of 1281.91, indicating a neutral trend. The MACD of -5.29 indicates Positive momentum. The RSI at 44.25 is Neutral, neither overbought nor oversold. The STOCH value of 22.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7358.

Poppins Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥17.70B15.332.24%-1.20%-8.71%
77
Outperform
¥18.18B17.642.55%3.18%-21.69%
75
Outperform
¥9.36B13.271.88%10.06%4.96%
74
Outperform
¥14.05B15.422.78%7.89%-12.90%
68
Neutral
¥9.03B9.083.22%53.89%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
44
Neutral
¥2.12B-18.74%-1062.47%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7358
Poppins Corporation
1,439.00
129.36
9.88%
JP:6571
QB Net Holdings Co., Ltd.
1,375.00
401.93
41.31%
JP:7378
ASIRO Inc.
1,173.00
153.16
15.02%
JP:7523
Art Vivant Co., Ltd.
2,006.00
1,075.54
115.59%
JP:7578
Nichiryoku Co., Ltd.
123.00
-17.00
-12.14%
JP:9262
SILVER LIFE CO.,LTD.
868.00
156.64
22.02%

Poppins Corporation Corporate Events

Poppins Corporation’s Innovative Study on Learning Disorders: A Potential Game-Changer?
Oct 27, 2025

Study Overview: Poppins Corporation is conducting an observational follow-up study titled ‘Observational Follow-up Study Examining the Medium-term Effect on Non-inferiority of the Previous Training With the Digital Medical Device (DMD) Poppins Clinical for Cognitive and Musical Training in Addition to Bi-monthly Speech and Reading Therapy Sessions on the Reading and Writing Abilities of Pediatric Patients With Specific Learning Disorders Involving Reading and/or Writing Deficits (SLD Reading) Compared to a Control Group Receiving Weekly Speech and Reading Therapy Sessions (POPPINS-02-b, Ancillary Study to POPPINS-02).’ The study aims to evaluate the medium-term effects of the Poppins Clinical device on improving reading and writing abilities in children with specific learning disorders, compared to traditional therapy methods.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025